ArticleFrontiers in oncology2022

PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells From Patients With Colorectal Cancer: Potential Value in Clinical Practice.

Xiao-Cui Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.